Service

BASF excipients for solubilization: Breaking
new ground in solubility and bioavailability

At BASF, we understand that even the most promising active ingredient is of no use unless it can be
effectively solubilized and made bioavailable. So we designed our solubilization portfolio to meet the
toughest challenges. Our extensive range of solubilizers, cosolvents and matrices for all common dosage
forms – including solids, liquids and semi-solids – includes novel excipients particularly well-suited for
poorly soluble drugs.

Selecting the right solubilization product and technology for a poorly soluble API often involves a lot of
trial and error. But when you partner with our experts, you can tap into their extensive solubilization
expertise and experience with all key technologies such as hot-melt extrusion, spray drying, and drug
layering. What’s more, they have access to industry-leading tools such as our high-throughput screening
(HTS) robot – putting them in an excellent position to help customers tackle their solubilization and
bioavailability challenges rapidly and efficiently.

Why partner with BASF?

• Broad portfolio for all common dosage forms
• Innovative excipients for poorly soluble APIs
• Proven performance and safety
• Experience with key technologies such as hot-melt extrusion